Japanese Encephalitis News and Research

RSS

Japanese encephalitis (previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito-borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae. Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may cause severe symptoms. One of the most important vectors of this disease is the mosquito ''Culex tritaeniorhynchus''. This disease is most prevalent in Southeast Asia and the Far East.

New model can estimate regional disease burden and impact of vaccination

Researchers have developed a model that can estimate regional disease burden and the impact of vaccination, even in the absence of robust surveillance data, a study in eLife reveals.

9 Jun 2020

T cells can counteract dangerous phenomenon of mosquito-borne viruses

Every year, more than 68,000 people end up with a clinical case of Japanese encephalitis. One in four of these patients will die. The mosquito-borne virus, which is most common in Southeast Asia, also causes severe neurological damage and psychiatric disorders.

5 Jun 2020

Can Chlorpromazine help treat COVID-19?

A new research paper published in the journal L'Encéphale in May 2020 reports on the planned ReCoVery Study, which will examine the possibility of repurposing the antipsychotic drug chlorpromazine for the treatment of COVID-19.

25 May 2020

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.

12 May 2020

Experimental vaccine could be effective against both Zika and Dengue

Walter Reed army institute of research has shown that a new vaccine against the Zika virus could be effective against both Zika and dengue virus. The study titled, “Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue experienced donor,” in the latest issue of the journal Nature Medicine.

3 Feb 2020

UMSOM receives landmark contract from NIAID for influenza research

Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine and Dean E. Albert Reece, MD, PhD, MBA, announced that CVD has been awarded a contract from the National Institute of Allergy and Infectious Diseases, with total funding up to more than $200 million over seven years if all contract options are exercised.

20 Sep 2019

IVI and MCRI to coordinate global push for developing vaccine against Strep A bacteria

The International Vaccine Institute and Australia's Murdoch Children's Research Institute will coordinate a global push to free the world of Group A Streptococcus, the contagious bacteria that kills half a million people every year and is developing resistance to antibiotics.

31 May 2019

Innovative model identifies primate species with potential to transmit Zika in the Americas

In the Americas, primate species likely to harbor Zika - and potentially transmit the virus - are common, abundant, and often live near people. So reports a new study published today in Epidemics. Findings are based on an innovative model developed by a collaborative team of researchers from Cary Institute of Ecosystem Studies and IBM Research through its Science for Social Good initiative.

19 Mar 2019

Cellular protein that interacts with viruses appears to enable infection process of Zika virus

A cellular protein that interacts with invading viruses appears to help enable the infection process of the Zika virus, according to an international team of researchers who suggest this protein could be a key target in developing new therapies to prevent or treat Zika virus infection.

17 Jan 2019

Scientists identify wildlife species that are most likely to host flaviviruses

After collecting data and comparing it with every known mammal and bird species on Earth, scientists from the University of California, Davis, have identified wildlife species that are the most likely to host flaviviruses such as Zika, West Nile, dengue and yellow fever.

6 Jan 2019

The Native Antigen Company launches ground-breaking Zika virus immunoassays

The Native Antigen Company has launched a series of ground-breaking immunoassays for Zika virus, offering researchers in academia, public health and drug discovery the capability to work with unprecedented levels of specificity and sensitivity.

29 Nov 2018

New vaccine could protect unborn babies from Zika virus

Until recently, the Zika virus was not a priority since it affected relatively few people and the cost of creating a vaccine was estimated at EUR 149-468 million. But the spread of Zika in the Americas and discovery of a link with reduced head size and brain damage in babies of women infected while pregnant changed that.

20 Jul 2018

Japanese Encephalitis News and Research

Further Reading

New model can estimate regional disease burden and impact of vaccination

T cells can counteract dangerous phenomenon of mosquito-borne viruses

Can Chlorpromazine help treat COVID-19?

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Experimental vaccine could be effective against both Zika and Dengue

UMSOM receives landmark contract from NIAID for influenza research

IVI and MCRI to coordinate global push for developing vaccine against Strep A bacteria

Innovative model identifies primate species with potential to transmit Zika in the Americas

Cellular protein that interacts with viruses appears to enable infection process of Zika virus

Scientists identify wildlife species that are most likely to host flaviviruses

The Native Antigen Company launches ground-breaking Zika virus immunoassays

New vaccine could protect unborn babies from Zika virus

Scientists discover secret to success of antiviral gene

Investigational ZPIV vaccine found to be safe and immunogenic in trial participants

Scientists make significant discovery in efforts to develop vaccine against global pathogens

Vaccination efforts in poor countries prevent 20 million deaths, provide economic benefits

Researchers investigate how previous exposure to West Nile virus affects Zika infection

Scientists solve structure of protein crucial to reproduction and spread of Zika virus

Researchers map key Zika virus protein to accelerate search for cure

Researchers find high-resolution structure of immature Zika virus

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Latest News